Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Novel strategies to manage CAR-T cell toxicity
Arthur Mulvey, Lionel Trueb, George Coukos, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy
Bhanuprakash Ananthakumar, Nagashri Nanjundeshwara, Archana Lakshmaiah, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 391-418
Closed Access | Times Cited: 5
Blood cancer therapy with synthetic receptors and CRISPR technology
Haiying Zhang, Mingxin Zhong, Jingdong Zhang, et al.
Leukemia Research (2025) Vol. 150, pp. 107646-107646
Closed Access
Ligand-restricted synNotch switches enable precision cell therapy
Xuyang Li, Dan Hu
Trends in Immunology (2025)
Closed Access
Exploring Structure—Function Relationships in Engineered Receptor Performance Using Computational Structure Prediction
William K. Corcoran, Amparo Cosio, Hailey I. Edelstein, et al.
GEN Biotechnology (2025) Vol. 4, Iss. 1, pp. 37-55
Closed Access
Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation
Jianhua Luo, Meng Guo, Mingyan Huang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Engineered immune cells as therapeutics for autoimmune diseases
Moncef Zouali
Trends in biotechnology (2024) Vol. 42, Iss. 7, pp. 842-858
Closed Access | Times Cited: 4
Designer mammalian living materials through genetic engineering
Mariana Gameiro, J. Almeida-Pinto, Beatriz S. Moura, et al.
Bioactive Materials (2025) Vol. 48, pp. 135-148
Closed Access
Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments
Tomás Gabriel Bas, Vannessa Duarte
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 925-925
Open Access | Times Cited: 2
SynNotch-Programmed Macrophages for Cancerous Cell Detection and Sensing
Tao Wang, Cia‐Hin Lau, Naian Wang, et al.
ACS Sensors (2024) Vol. 9, Iss. 11, pp. 6136-6147
Closed Access | Times Cited: 2
Advances in Bioinspired Artificial Systems Enabling Biomarker‐Driven Therapy
Meixia Wang, Huan Zhong, Yangbing Li, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 48
Closed Access | Times Cited: 1
Exploring structure-function relationships in engineered receptor performance using computational structure prediction
William K. Corcoran, Amparo Cosio, Hailey I. Edelstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Exploring the potential of CAR-macrophage therapy
Yongyu Shi, Xia Li, Yan Dong, et al.
Life Sciences (2024) Vol. 361, pp. 123300-123300
Closed Access | Times Cited: 1
An engineering perspective on transcription, translation and their regulation
Jarosław Śmieja
Postępy Biochemii (2024) Vol. 70, Iss. 1, pp. 88-94
Open Access
Positions of cysteine residues reveal local clusters and hidden relationships to Sequons and Transmembrane domains in Human proteins
Manthan Desai, Bingyun Sun
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Engineering a controllable and reversible switch for CAR-based cellular immunotherapies via a genetic code expansion system
Yue Liu, Lingna An, Xiaoqi Wang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access
Page 1

Scroll to top